Swiss National Bank - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 246 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,170,147
+23.6%
189,765
+1.0%
0.00%
+33.3%
Q2 2023$4,182,221
-7.7%
187,965
-10.1%
0.00%0.0%
Q1 2023$4,530,514
-4.2%
209,165
-10.1%
0.00%0.0%
Q4 2022$4,727,457
-18.7%
232,765
+2.6%
0.00%
-25.0%
Q3 2022$5,814,000
+8.8%
226,765
+0.9%
0.00%0.0%
Q2 2022$5,343,000
-8.5%
224,665
-13.4%
0.00%
+33.3%
Q1 2022$5,841,000
+21.5%
259,365
+6.8%
0.00%0.0%
Q4 2021$4,809,000
-0.5%
242,865
-1.2%
0.00%0.0%
Q3 2021$4,835,000
-10.5%
245,7000.0%0.00%0.0%
Q2 2021$5,405,000
-9.9%
245,700
-2.6%
0.00%
-25.0%
Q1 2021$6,000,000
-7.6%
252,200
+1.6%
0.00%
-20.0%
Q4 2020$6,493,000
+51.1%
248,200
+0.6%
0.01%
+66.7%
Q3 2020$4,296,000
+5.1%
246,800
+1.5%
0.00%0.0%
Q2 2020$4,089,000
+72.4%
243,100
+21.9%
0.00%0.0%
Q1 2020$2,372,000
+0.1%
199,500
+1.8%
0.00%
+50.0%
Q4 2019$2,370,000
-13.5%
195,900
+1.0%
0.00%
-33.3%
Q3 2019$2,741,000
+28.0%
193,900
+0.9%
0.00%
+50.0%
Q2 2019$2,142,000
-3.7%
192,100
+1.4%
0.00%0.0%
Q1 2019$2,224,000
-9.9%
189,400
+2.5%
0.00%
-33.3%
Q4 2018$2,468,000
-1.6%
184,700
+3.2%
0.00%0.0%
Q3 2018$2,508,000
-10.8%
178,9000.0%0.00%0.0%
Q2 2018$2,812,000
+15.2%
178,900
+20.6%
0.00%0.0%
Q1 2018$2,440,000
-5.6%
148,300
+3.6%
0.00%0.0%
Q4 2017$2,586,000
-3.4%
143,200
+3.2%
0.00%0.0%
Q3 2017$2,677,000
+63.5%
138,7000.0%0.00%
+50.0%
Q2 2017$1,637,000
+16.5%
138,700
+8.2%
0.00%0.0%
Q1 2017$1,405,000
+50.9%
128,2000.0%0.00%
+100.0%
Q4 2016$931,000
+11.8%
128,2000.0%0.00%0.0%
Q3 2016$833,000
+19.0%
128,2000.0%0.00%0.0%
Q2 2016$700,000
+40.0%
128,200
+16.0%
0.00%0.0%
Q1 2016$500,000
+10.6%
110,500
+21.8%
0.00%0.0%
Q4 2015$452,000
+32.6%
90,7000.0%0.00%0.0%
Q3 2015$341,000
-25.9%
90,700
+18.6%
0.00%0.0%
Q2 2015$460,000
+196.8%
76,500
-21.6%
0.00%0.0%
Q3 2013$155,000
-8.3%
97,6000.0%0.00%0.0%
Q2 2013$169,00097,6000.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 6,911,376$155,644,0006.95%
Parallel Advisors, LLC 1,944,319$47,014,0001.86%
TANAKA CAPITAL MANAGEMENT INC 39,289$885,0001.79%
S&T BANK/PA 508,546$11,452,0001.73%
Bridge City Capital, LLC 83,967$1,891,0000.88%
Birchview Capital, LP 50,000$1,126,0000.81%
Quantedge Capital Pte Ltd 113,012$2,545,0000.75%
FAS Wealth Partners, Inc. 289,625$6,522,0000.61%
AJ WEALTH STRATEGIES, LLC 396,029$8,919,0000.44%
TRUSTCORE FINANCIAL SERVICES, LLC 208,806$4,702,0000.41%
View complete list of CORCEPT THERAPEUTICS INC shareholders